TERESA HUNT: Open Payments
NPI 1518389857 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,335 in 71 payments from 16 companies in 2025. Trend: 2023 $523 · 2024 $316 · 2025 $1,335
Food & beverage: $1,335
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $275 |
| Regeneron Healthcare Solutions, Inc. | 8 | $225 |
| Organon LLC | 10 | $149 |
| UCB, Inc. | 7 | $126 |
| Novartis Pharmaceuticals Corporation | 6 | $121 |
| Botanix SB Inc | 4 | $90 |
| Janssen Biotech, Inc. | 4 | $74 |
| ABBVIE INC. | 3 | $67 |
| Verrica Pharmaceuticals Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $34 |
Products named: DUPIXENT, VTAMA, Bimzelx, COSENTYX, LIBTAYO, SOFDRA, TREMFYA, SKYRIZI.
Industry payments across AZ — which companies pay providers there.
